Guangtong Deng[Author] - Search Results

Year	Number of Results
2016	2
2017	1
2019	4
2020	16
2021	5
2022	11
2023	21
2024	2

1

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Zhou Q, et al. Among authors: deng g. Signal Transduct Target Ther. 2024 Mar 8;9(1):55. doi: 10.1038/s41392-024-01769-5. Signal Transduct Target Ther. 2024. PMID: 38453898 Free PMC article. Review.

2

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities.

Dian Y, Meng Y, Sun Y, Deng G, Zeng F. Dian Y, et al. Among authors: deng g. J Infect. 2023 Aug;87(2):e24-e27. doi: 10.1016/j.jinf.2023.05.012. Epub 2023 May 17. J Infect. 2023. PMID: 37207823 Free PMC article. No abstract available.

3

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis.

Zeng F, Ye L, Zhou Q, He Y, Zhang Y, Deng G, Chen X, Liu H. Zeng F, et al. Among authors: deng g. Redox Biol. 2023 May;61:102653. doi: 10.1016/j.redox.2023.102653. Epub 2023 Mar 1. Redox Biol. 2023. PMID: 36889082 Free PMC article.

4

BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway.

Deng G, Zeng F, Su J, Zhao S, Hu R, Zhu W, Hu S, Chen X, Yin M. Deng G, et al. Theranostics. 2020 Sep 15;10(25):11428-11443. doi: 10.7150/thno.47432. eCollection 2020. Theranostics. 2020. PMID: 33052224 Free PMC article.

5

Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.

Deng G, Li D, Sun Y, Jin L, Zhou Q, Xiao C, Wu Q, Sun H, Dian Y, Zeng F, Pan P, Shen M. Deng G, et al. J Med Virol. 2023 Apr;95(4):e28756. doi: 10.1002/jmv.28756. J Med Virol. 2023. PMID: 37185838

6

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.

Du S, Zeng F, Sun H, Liu Y, Han P, Zhang B, Xue W, Deng G, Yin M, Cui B. Du S, et al. Among authors: deng g. Bioengineered. 2022 Feb;13(2):2498-2512. doi: 10.1080/21655979.2021.2017627. Bioengineered. 2022. PMID: 35067161 Free PMC article.

7

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.

Sun Y, Jin L, Dian Y, Shen M, Zeng F, Chen X, Deng G. Sun Y, et al. Among authors: deng g. EClinicalMedicine. 2023 May 5;59:101981. doi: 10.1016/j.eclinm.2023.101981. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37193346 Free PMC article.

8

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression.

Zeng F, Li Y, Meng Y, Sun H, He Y, Yin M, Chen X, Deng G. Zeng F, et al. Among authors: deng g. Exp Mol Med. 2023 Feb;55(2):364-376. doi: 10.1038/s12276-023-00936-y. Epub 2023 Feb 1. Exp Mol Med. 2023. PMID: 36720918 Free PMC article.

9

Gastric cancer: An epigenetic view.

Tang SY, Zhou PJ, Meng Y, Zeng FR, Deng GT. Tang SY, et al. World J Gastrointest Oncol. 2022 Jan 15;14(1):90-109. doi: 10.4251/wjgo.v14.i1.90. World J Gastrointest Oncol. 2022. PMID: 35116105 Free PMC article. Review.

10

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy.

Du S, Zeng F, Deng G. Du S, et al. Among authors: deng g. Signal Transduct Target Ther. 2023 Feb 22;8(1):77. doi: 10.1038/s41392-023-01357-z. Signal Transduct Target Ther. 2023. PMID: 36813764 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year